November 04, 2025

New Poll: Only 1 in 3 Link Alcohol to Cancer

“Individuals who drink alcohol were more likely to believe that alcohol consumption has no effect on cancer risk, which is alarming, given the growing burden of alcohol-related cancers in the United States."

Conexiant

November 03, 2025

Cardiologist Sheng Fu, M.D., Joins Baptist Health Heart & Vascular Care at Baptist Health Miami Cardiac & Vascular Institute

Board-certified advanced heart failure and transplant cardiologist Sheng Fu, M.D., has joined Baptist Health Heart & Vascular Care at Baptist Health Miami Cardiac & Vascular Institute.

Baptist Health South Florida

October 17, 2025

Your Guide to Referring to the Center for Heart Rhythm Disorders

The Center for Heart Rhythm Disorders at Miami Cardiac & Vascular Institute offers streamlined, expert evaluation and management of arrhythmias.

Baptist Health South Florida

October 15, 2025

Dana-Farber Research News 10.15.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from September 16 - September 30.

Dana-Farber

October 14, 2025

FDA Approves Combination Regimen for Extensive-Stage SCLC

Lurbinectedin (Zepzelca) in combination with atezolizumab (Tecentriq) or atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza) was approved for maintenance treatment of adults with extensive-stage s...

The ASCO Post

October 09, 2025

Green Propellants and the Future of Metered Dose Inhalers

The pressure is on to reduce the carbon footprint of respiratory drugs by using next-generation green propellants

The Medicine Maker

October 08, 2025

Risk vs. Benefit: Clinical Trial Aims to Identify Patients with Early-Stage NSCLC Who May Not Need Immunotherapy After Surgery

Many patients with early-stage non-small cell lung cancer (NSCLC) are treated post-surgery with the monoclonal antibody durvalumab (brand name Imfinzi) — an FDA-approved regimen.

Roswell Park Comprehensive Cancer Center

October 07, 2025

Newer Radiation Technique Reduces Side Effects While Maintaining Effectiveness

Researchers at Fox Chase Cancer Center have demonstrated that pulsed low dose rate (PLDR) chemoradiation therapy can significantly reduce side effects while maintaining treatment effectiveness for patients with esophageal cancer and non-small cell lung cancer.

Fox Chase Cancer Center

July 12, 2023

Changing How Immune Checkpoint Inhibitors Are Delivered Could Reduce Costs by 14%, Study Finds

Investigators have found that millions of dollars could be saved annually across the Veterans Health Administration by reconsidering how immune checkpoint inhibitors are delivered, according to a new ...

The ASCO Post